|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 529426-529450 of 2315033 (92602 Page(s) Totally)
<< < 21173 21174 21175 21176 21177 21178 21179 21180 21181 21182 > >>
View [10|25|50] records per page
| 國立交通大學 |
2016-03-28T08:17:27Z |
IVVS：智慧車用視訊雷達系統研發計畫---子計畫四：即時超高畫質車用視訊編碼(II)
|
張添烜; Chang Tian-Sheuan |
| 國立交通大學 |
2016-03-29T00:01:09Z |
IVVS：智慧車用視訊雷達系統研發計畫---子計畫四：即時超高畫質車用視訊編碼(II)
|
張添烜; Chang Tian-Sheuan |
| 國立交通大學 |
2014-12-13T10:44:21Z |
IVVS：智慧車用視訊雷達系統研發計畫---總計畫暨子計畫一：540 度半球狀環場鏡頭陣列視訊合成技術與物件感知之高動態夜視處理技術
|
郭峻因; GUO JIUN-IN |
| 國立交通大學 |
2016-03-28T08:17:44Z |
IVVS：智慧車用視訊雷達系統研發計畫---總計畫暨子計畫一：540 度半球狀環場鏡頭陣列視訊合成技術與物件感知之高動態夜視處理技術
|
郭峻因; GUO JIUN-IN |
| 國立交通大學 |
2016-03-29T00:01:11Z |
IVVS：智慧車用視訊雷達系統研發計畫---總計畫暨子計畫一：540 度半球狀環場鏡頭陣列視訊合成技術與物件感知之高動態夜視處理技術
|
郭峻因; GUO JIUN-IN |
| 國立交通大學 |
2016-03-29T00:01:04Z |
IVVS：智慧車用視訊雷達系統研發計畫---總計畫暨子計畫一：540 度半球狀環場鏡頭陣列視訊合成技術與物件感知之高動態夜視處理技術
|
Anonymous |
| 淡江大學 |
2002-01-01 |
IVY管理個案叢書
|
黃國隆(等策劃) |
| 國立成功大學 |
2022-11-25 |
IV族和III-VI族二維材料的多樣準粒子性質
|
武康田; Dien, Vo Khuong |
| 中山醫學大學 |
2009-05-28 |
IWA Specialty Conference:2nd International Symposium on Water and Wastewater on Ancient Civilization
|
童伊迪 |
| 國立政治大學 |
2010 |
IWakeUp: A video-based alarm clock for smart bedrooms
|
Liao, Wen-Hung;Kuo, Jen Ho;Yang, Chien-Ming;Chen, Ivy Y.; 廖文宏;郭仁和;楊建銘 |
| 國立政治大學 |
2010.07 |
iWakeUp: An Intelligent Video-Based Alarm Clock
|
Liao, Wen‐Hung ; Kuo, Jen‐Ho ; Yang, Chien‐Ming ; Chen,Ivy Y. |
| 國立臺灣科技大學 |
2014-04 |
iWash
|
馬彗娟;程彥彰;馮睦淳 |
| 國立臺灣科技大學 |
2014-04 |
iWash
|
馬彗娟;程彥彰;馮睦淳 |
| 臺大學術典藏 |
2020-01-06T03:05:27Z |
IWMCG-4 - Proceedings of the Fourth International Workshop on Modeling in Crystal Growth - 4-7 November 2003 - Kyushu, Japan - Preface
|
Lan, C. W.; Imaishi, N.; Kakimoto, K.; CHUNG-WEN LAN |
| 國立成功大學 |
2005-01 |
IWR: Interactive WWW response in the wireless and mobile environment using the concept of universal WWW access
|
Huang, Chung-Ming; Chao, Yu-Chang |
| 國立臺灣科技大學 |
2007 |
IWTRP: Spatial-reuse enhancement of the wireless token ring protocol
|
Cheng, R.-G.;Chang, R.-I.;Hua, K.-L. |
| 中山醫學大學 |
2020 |
Ixekizumab for the treatment of ankylosing spondylitis
|
Huang, JX; Lee, YH; Wei, JCC |
| 臺大學術典藏 |
2018-09-10T18:07:35Z |
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
|
Nash, P. and Kirkham, B. and Okada, M. and Rahman, P. and Combe, B. and Burmester, G.-R. and Adams, D.H. and Kerr, L. and Lee, C. and Shuler, C.L. and Genovese, M. and Ahmed, K. and Alper, J. and Barkham, N. and Bennett, R.E. and Garc\\'ia, F.J.B. and Alonso, R.B. and Blumstein, H.B. and Brooks, M.S. and Burmester, G.-R. and Cagnoli, P. and Caldron, P.H. and Cantagrel, A. and Chen, D.-Y. and Churchill, M.A. and Codding, C.E. and Combe, B. and Deane, P.M.G. and Del Giudice, J. and Deodhar, A.A. and Dhar, R.K. and Dokoupilova, E. and Egan, R.M. and Everding, A. and Gal\\'indez, E. and Genovese, M. and Goddard, D.H. and Gottlieb, A. and Goupille, P. and Griffin, R.M. and Gupta, R.C. and Hall, S. and Hatti, K. and Howell, M.P. and Huang, Y.-H. and Jajoo, R. and Janssen, N.M. and Kiltz, U. and Kivitz, A.J. and Klein, S.J. and Korkosz, M.P. and Kotha, R. and Kremer, J.M. and Lue, C. and de la Fuente, J.L.M. and Marzo-Ortega, H. and Masmitja, J.G. and Mease, P.J. and Meroni, P.L. and Mueller, E.C. and Nandagudi, A.C. and Nash, P. and Fern\\'andez-Nebro, A. and Neuwelt, C.M. and Orbai, A.M. and Oza, M.R. and Parks, D.L. and Pattanaik, D. and Rell-Bakalarska, M.E. and Rosmarin, D. and Roussou, E. and Rychlewska-Hanczewksa, A.I. and Sikes, D.H. and Stack, M.T. and Sunkureddi, P. and Tahir, H. and Tha?i, D. and Tsai, T.-F. and Turkiewicz, A.M. and Unger, L. and Cabello, R.V. and Wagner, U. and Wei, C.-C. and Wells, A.F. and Youssef, P. and Zielinska, A.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:50Z |
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
|
Okada M.; Kirkham B.; Nash P.; Nash P.;Kirkham B.;Okada M.;Rahman P.;Combe B.;Burmester G.-R.;Adams D.H.;Kerr L.;Lee C.;Shuler C.L.;Genovese M.;Ahmed K.;Alper J.;Barkham N.;Bennett R.E.;Garc?A F.J.B.;Alonso R.B.;Blumstein H.B.;Brooks M.S.;Burmester G.-R.;Cagnoli P.;Caldron P.H.;Cantagrel A.;Chen D.-Y.;Churchill M.A.;Jr, Codding C.E.;Combe B.;Deane P.M.G.;Del Giudice J.;Deodhar A.A.;Dhar R.K.;Dokoupilova E.;Egan R.M.;Everding A.;Gal?Ndez E.;Genovese M.;Goddard D.H.;Gottlieb A.;Goupille P.;Griffin R.M.;Gupta R.C.;Hall S.;Hatti K.;Howell M.P.;Huang Y.-H.;Jajoo R.;Janssen N.M.;Kiltz U.;Kivitz A.J.;Klein S.J.;Korkosz M.P.;Kotha R.;Kremer J.M.;Lue C.;De La Fuente J.L.M.;Marzo-Ortega H.;Masmitja J.G.;Mease P.J.;Meroni P.L.;Mueller E.C.;Nandagudi A.C.;Nash P.;Fern?Ndez-Nebro A.;Neuwelt C.M.;Orbai A.M.;Oza M.R.;Parks D.L.;Pattanaik D.;Rell-Bakalarska M.E.;Rosmarin D.;Roussou E.;Rychlewska-Hanczewksa A.I.;Sikes D.H.;Stack M.T.;Sunkureddi P.;Tahir H.;Tha?I D.;Tsen-Fang Tsai;Turkiewicz A.M.;Unger L.;Cabello R.V.;Wagner U.;Wei C.-C.;Wells A.F.;Youssef P.;Zielinska A.; Korkosz M.P.; Klein S.J.; Kiltz U.; Kivitz A.J.; Janssen N.M.; Rahman P.; Combe B.; Burmester G.-R.; Adams D.H.; Kerr L.; Lee C.; Shuler C.L.; Genovese M.; Ahmed K.; Alper J.; Barkham N.; Bennett R.E.; Garc?a F.J.B.; Alonso R.B.; Blumstein H.B.; Brooks M.S.; Burmester G.-R.; Cagnoli P.; Caldron P.H.; Cantagrel A.; Chen D.-Y.; Churchill M.A.; Jr, Codding C.E.; Combe B.; Deane P.M.G.; Del Giudice J.; Deodhar A.A.; Dhar R.K.; Dokoupilova E.; Egan R.M.; Everding A.; Gal?ndez E.; Genovese M.; Goddard D.H.; Gottlieb A.; Goupille P.; Griffin R.M.; Gupta R.C.; Hall S.; Hatti K.; Howell M.P.; Huang Y.-H.; Jajoo R.; Zielinska A.; Wells A.F.; Youssef P.; Kotha R.; Kremer J.M.; Lue C.; de la Fuente J.L.M.; Marzo-Ortega H.; Masmitja J.G.; Mease P.J.; Meroni P.L.; Mueller E.C.; Nandagudi A.C.; Nash P.; Fern?ndez-Nebro A.; Neuwelt C.M.; Orbai A.M.; Oza M.R.; Parks D.L.; Pattanaik D.; Rell-Bakalarska M.E.; Rosmarin D.; Roussou E.; Rychlewska-Hanczewksa A.I.; Sikes D.H.; Stack M.T.; Sunkureddi P.; Tahir H.; Tha?i D.; TSEN-FANG TSAI; Turkiewicz A.M.; Unger L.; Cabello R.V.; Wagner U.; Wei C.-C. |
| 中山醫學大學 |
2021 |
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies
|
Kiltz, U; Wei, JCC; van der Heijde, D; van den Bosch, F; Walsh, JA; Boonen, A; Gensler, LS; Hunter, T; Carlier, H; Dong, Y; Li, XQ; Bolce, R; Strand, V; Braun, J |
| 臺大學術典藏 |
2021-10-28T07:11:15Z |
Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies
|
Combe B.; TSEN-FANG TSAI; Huffstutter J.E.; Sprabery A.T.; Lin C.-Y.; Park S.Y.; Kronbergs A.; Hufford M.M.; Nash P. |
| 臺北醫學大學 |
2008-02 |
Ixel® / 鬱思樂®膠囊
|
藥劑部 |
| 南台科技大學 |
2002-06 |
IXIA-APTS: 網路設備自動檢測機制之研發與建置
|
張明裕; 李昶清 |
| 中國醫藥大學 |
2012-09 |
Ixora parviflora Protects against UVB-Induced Photoaging by Inhibiting the Expression of MMPs, MAP Kinases, and COX-2 and by Promoting Type I Procollagen Synthesis
|
溫國慶(Kuo-Ching Wen);(Pei-Ching Fan);蔡尚元(Shang-Yuan Tsai);(I-Chen Shih);江秀梅(Hsiu-Mei Chiang)* |
| 中國醫藥大學 |
2014-10-24 |
Ixora parviflora protects against UVB-induced photoaging by inhibiting the expression of MMPs, MAP kinases, and COX-2 and by promoting type I procollagen synthesis
|
溫國慶(Kuo-Ching Wen);范沛晴(Pei-Ching Fan);施宜貞(I-Chen Shih);江秀梅(Hsiu-Mei Chiang)* |
显示项目 529426-529450 / 2315033 (共92602页)
<< < 21173 21174 21175 21176 21177 21178 21179 21180 21181 21182 > >>
每页显示[10|25|50]项目
|
